Tibotec (part of Johnson & Johnson)

Tibotec website: www.tibotec.com  

🔎 Run a search for “Tibotec (part of Johnson & Johnson)”

Get RSS feed of these results

All stories

Article
18 July 2011
+ Français - Hide

Author: Médecins Sans Frontières

Selon un rapport publié aujourd'hui par Médecins Sans Frontières (MSF) lors de la Conférence de l'International AIDS Society à Rome, plusieurs compagnies pharmaceutiques ont interrompu les programmes de réduction du coût des médicaments antirétroviraux...

Read more

Article
25 April 2011

Johnson & Johnson takes heat from Doctors Without Borders for not sharing HIV drug patents [USA]

Author: Susan Todd, Star Ledger [USA]

Doctors without Borders criticized Johnson & Johnson today for refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries…"Johnson & Johnson…has chosen to turn its...

Read more

Article
28 January 2011

J&J Generics Deal May Speed AIDS Drug Access in Africa, India

Author: Alex Nussbaum, Bloomberg [USA]

...Tibotec Pharmaceuticals [part of Johnson & Johnson]...has agreed to let three generic drugmakers provide copies of [its experimental AIDS drug] in sub-Saharan Africa, India and parts of Asia if it’s approved by regulators...[T]hat could make...

Read more

Article
15 December 2009
+ Français - Hide

Author: AFP

Une "communauté de brevets" pour la production de médicaments à moindres coûts contre le sida va commencer à opérer à la mi-2010, a annoncé lundi soir la Facilité internationale d'achats de médicaments (Unitaid)... Cette création est le fruit de...

Read more

Article
5 June 2008

Boehringer, Gilead Freeze Antiretroviral Prices for Some U.S. Agencies [USA]

Author: Kaiser Daily HIV/AIDS Report [USA]

Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S..."We urge the other drug companies to follow [Boehringer's] and Gilead's lead and to freeze price...

Read more

Article
11 March 2008

Microbicide Developer Receives License for Novel HIV Microbicide Candidate from Merck & Co., Inc.

Author: International Partnerships for Microbicides

…Merck & Co., Inc., has agreed to provide a royalty-free license to the non-profit International Partnership for Microbicides (IPM) to develop a novel antiretroviral compound for use as a potential vaginal microbicide…“Merck deserves recognition...

Read more

Article
5 April 2007

Aspen to market last-resort Aids drug across Africa

Author: Samantha Enslin, Business Report [So. Africa]

Aspen plans to market a salvage treatment, Prezista, for Aids patients in 20 sub-Saharan African countries through a deal with Ireland's Tibotec Pharmaceuticals [a division of Johnson & Johnson (J&J)]...The deal was structured so that Aspen...

Read more

Story
1 January 2007
+ Français - Hide
Article
1 January 2007
+ Français - Hide

Author: Les Entreprises du Médicament [France]

[annexe présente exemples d’actions & partenariats des Entreprises du Médicament: Novartis, sanofi-aventis, MSD (Merck Sharp & Dohme, partie de Merck), Laboratoires Pierre Fabre, Bayer, Novo Nordisk (partie de Novo Group), GlaxoSmithKline,...

Read more

Article
1 December 2006

Pharma Companies Need to Keep Improving AIDS Response, Says ICCR and Nigerian Doctor

Author: William Baue, SocialFunds

In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) produced the most thorough study of pharmaceutical company action on HIV/AIDS, documenting how the industry falls significantly short of best practice...The Business and Human...

Read more